바이오노트

377740KOSPI의료용품 및 기타 의약 관련제품 제조업

58.7 / 100

Reference Date: 2026-04-13

Financial Score28.0 / 40

News Sentiment16.7 / 25

Momentum7.0 / 20

Disclosure7.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 8.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

BIONOTE is a company established in 2003 specializing in animal diagnostic products and bio-content, leveraging its proprietary recombinant antigen and antibody technology to develop and manufacture rapid immunodiagnostic, enzyme-linked immunosorbent assay (ELISA), and related products. Key offerings include the BIONOTE Rapid and Vcheck F brands, used in veterinary clinics and farms, with expansion into human in vitro diagnostic (IVD) raw material supply.

Number of Employees

334people

Average Salary

49.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 19.894.0Point

PBR

0.33Industry Average 1.627.0Point

Half of industry avg (excellent)

ROE

-5.56Industry Average -4.893.5Point

In line with industry avg

Debt Ratio

2.09Industry Average 8.888.0Point

Half of industry avg (excellent)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲14.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲81.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -1.1% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 1Neutral 5Negative 0Average Sentiment Score 66.7

Neutral
오늘의 메모[3월 31일]
바이오노트는 주식소각으로 인한 주권변경상장이 있었습니다.
Neutral
동구바이오제약, 처방약 경쟁력 여전…"신성장동력 성과 본격화"
동구바이오제약이 전문의약품 및 CDMO 사업 경쟁력을 강화하고 신규 사업 확장에 속도를 내고 있다.
Neutral
오늘의 메모[3월 24일]
바이오노트의 주식매수선택권 행사로 인한 보통주 추가상장 소식이 공시되었다.

Detailed Momentum

52-week position3.0Point

52w lower range (27%)

Current 4,965Won52-week high 6,23052-week low 4,485

1-month return1.0Point

1m -8.73% (falling)

Volume trend3.0Point

Volume flat

Detailed Disclosure

6 totalPositive 0Neutral 5Negative 1

Negative소송등의제기ㆍ신청(자율공시:일정금액미만의청구)2026-03-31
Neutral정기주주총회결과2026-03-26
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-26
Neutral기업가치제고계획(자율공시)2026-03-26
Neutral사업보고서 (2025.12)2026-03-18